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In order to avoid publication bias, all trials should be registered at initiation and their results made easily accessible.
However, some trial results are more difficult to publish than others. This report describes one such trial and
highlights the need for a way of making results of trials widely available even if not presented in the traditional
format. Until such time as it is required by law both to register all trials and enter their final results into the
database, a lack of resources will mean that some trial results are never published. The scale of the problem of non-
publication is unknown and for valid trial results any form of publication is better than none. Therefore it is
essential that a quick and easy way is available to act as a safety net to catch trial results that would otherwise be
lost.
Keywords: Publication bias, Randomized trial, Polycythaemia, Busulphan, Radioactive phosphorous, VenesectionBackground
The problem of publication bias in scientific research
has been recognized for many years, and was drawn to
the attention of the medical community in the 1980s [1].
Since that time many studies have shown that lack, or
delay, of publication is related to the statistical signifi-
cance of the results [2-7]. Awareness of this has been
increased by the rise in systematic reviews, and methods
to assess the degree of publication bias in these have
been developed [8]. These methods provide a rating of
the quality of the evidence but do not help in determin-
ing a corrected effect estimate.
Some measures have already been put in place to
address the problem, such as the requirement that trials
must have been registered in a recognized public trials
registry at initiation as a condition of consideration
for publication in a journal that is a member of the
International Committee of Medical Journal Editors
[9]. Even for trials which have been registered, publi-
cation rates are low [10].
We discuss here one example that illustrates that there
may be additional ways of reducing this problem.* Correspondence: julie.burrett@ctsu.ox.ac.uk
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The Medical Research Council funded a randomized
trial in polycythaemia (Figure 1), which recruited be-
tween 1974 and 1993, before the days of trial registries.
Due to the low mortality rate from this disease, with a
median survival of 13 years, follow-up continued until
2003. During this time personnel working on the trial
changed, including the departure of the statistician. This
trial then came under the remit of the remaining statisti-
cian in the Clinical Trial Service Unit responsible for
leukemia trials, who reran analyses and wrote a skeleton
paper. The introduction, methods and results sections of
the paper were drafted, but the discussion section was
incomplete and the clinical lead then retired. The com-
puter system on which the analysis programs ran has
now been superseded. Although programs and data have
been archived it would take a considerable amount of
work to do any further analyses.
The paper remains without an abstract, discussion sec-
tion or references and there are no resources available
for any further work to be done. The trial was completed
and we strongly believe that the results should be made
publicly available. However, we have not found any journal
that would accept the paper in this format (see Additional
file 1: Medical Research Council randomized Polycythaemia
trial results: long term outcome after busulphan, radioactive
phosphorous or venesection).Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,

























Figure 1 Randomization structure showing the number of patients allocated to each of the three treatments (Venesection, P32 and
Busulphan) and the method of treatment allocation in each phase of the trial. Vn1, Pn2 and Bn3 indicate that n1 patients were allocated to
Venesection, n2 to P32 and n3 to Busulphan.
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Much recent discussion has focused on the issue of com-
peting, particularly financial, interests, and the role of the
pharmaceutical industry. This has led to a new US law re-
quiring both the registration of trials and the entry of final
results into a database [11], and the suggestion that legis-
lation should be expanded internationally [12]. However,
there are other reasons behind non-publication, including
a lack of resources, as in the example presented here.Conclusions
The scale of the non-publication of trials is unknown,
but providing a medium for reporting unpublished trials,
together with any results that are available from them,
would provide further information on this subject.Additional file
Additional file 1: Medical Research Council randomized
Polycythaemia trial results: long term outcome after busulphan,
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